- INCREASE (inhaled treprostinil)
-
Product
INCREASE
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase IIIINCREASE - Phase III clinical trial with Tyvaso® (treprostinil) for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD).
LEARN MORE Close - BREEZE Treprostinil Technosphere® (inhaled treprostinil)
-
Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 1 (PAH)Status
Phase IIIDry Powder Inhaled (DPI) treprostinil in a small handheld device for the treatment of pulmonary arterial hypertension (PAH).
LEARN MORE Close - PERFECT (inhaled treprostinil)
-
Product
PERFECT
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Pulmonary Hypertension (PH) WHO Group 3Status
Phase IIIPhase III clinical trial with Tyvaso® (treprostinil) for the treatment of pulmonary hypertension due to chronic obstructive pulmonary disease (PH-COPD).
LEARN MORE Close - TETON (inhaled treprostinil)
-
Product
TETON
(inhaled treprostinil)Therapeutic Platform
Tyvaso®Targeted Indication
Chronic Fibrosing Interstitial Lung DiseaseStatus
Phase IIIA Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Efficacy and Safety of Inhaled Treprostinil in Patients with Chronic Fibrosing Interstitial Lung Disease.
LEARN MORE Close
Menu
